Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RNAi
Biotech
Arrowhead sues Ionis over patent dispute for Tryngolza rival
If Arrowhead’s candidate gains FDA approval, it will face Ionis’ Tryngolza.
Gabrielle Masson
Sep 11, 2025 11:33am
Corsera launches with $50M for predictive AI tool, RNAi asset
Sep 2, 2025 6:30am
Biogen blueprints $1B CNS deal with RNAi biotech
May 27, 2025 10:55am
Sarepta, Arrowhead ink $1B-plus deal for seven programs
Nov 26, 2024 11:18am
Alnylam abandons clinical-stage Type 2 diabetes asset
Oct 31, 2024 10:27am
Roche, Alnylam celebrate second ph. 2 win for blood pressure med
Mar 5, 2024 9:05am
